Pegfilgrastim biosimilar (Eurofarma)
非格司亭生物类似药 (Eurofarma)
Report date: 2022/07/04 19:38:02
Base Information
Drug NamePegfilgrastim biosimilar (Eurofarma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEurofarma
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesEurofarma Laboratorios Sa
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A